Developing microRNA Therapeutics: Approaching the Unique Complexities
The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
MicroRNAs are endogenous small non-coding RNAs that regulate gene expression by interfering with translation or stability of target transcripts. The importance of microRNAs for maintaining biological functions is illustrated by the fact that microRNAs are exploited in nature to regulate phenotypes, and by the diverse disease phenotypes that result when microRNAs are mutated or improperly expressed. Disease-associated microRNAs might therefore represent a new class of therapeutic targets. With the recent demonstration that inhibition of miR-122 reduces viral load in hepatitis C patients, microRNA modulators are no longer merely theoretical, but rather, have become strong candidate therapeutics. The complexity of microRNA biology offers a novel mechanism of action for therapeutic intervention but also poses unique challenges for the development of therapeutic modulators as drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Transcriptome-wide Identification of RNA-Binding Protein and MicroRNA Target Sites by PAR-CLIP
Hafner, M., Landthaler, M., Burger, L., Khorshid, M., Hausser, J., Berninger, P., Rothballer, A., Ascano, M., Jungkamp, A.-C., Munschauer, M., et al. (2010) · Cell · doi:10.1016/j.cell.2010.03.009 · Cited by 2,873 · cited 2×
“MicroRNA targets sites in the coding region can trigger target regulation, although less effectively than target sites in the 3 ¢ UTR (Easow et al., 2007; Hafner et al., 2010).”
Gene silencing by microRNAs: contributions of translational repression and mRNA decay
Huntzinger, E., & Izaurralde, E. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2936 · Cited by 2,339
A pancreatic islet-specific microRNA regulates insulin secretion
Poy, M. N., Eliasson, L., Krutzfeldt, J., Kuwajima, S., Ma, X., MacDonald, P. E., Pfeffer, S., Tuschl, T., Rajewsky, N., Rorsman, P., et al. (2004) · Nature · doi:10.1038/nature03076 · Cited by 2,102 · cited 1×
“…with miR-10b precursor (Kim et al., 2011). miR-375. miR-375 was originally identified as a pancre-as-specific microRNA, where it functions in maintaining alpha and beta cell mass and regulates insulin secretion (Poy et al., 2004; Kloosterman et al., 2007; Avnit-Sagi et al., 2009; Poy et al., 2009).”
miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting
Esau, C., Davis, S., Murray, S. F., Yu, X. X., Pandey, S. K., Pear, M., Watts, L., Booten, S. L., Graham, M., McKay, R., et al. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.005 · Cited by 2,082 · cited 2×
“Using anti-miRs or antagomiRs to inhibit miR-122, multiple laboratories have demonstrated dose-dependent pharmacologic effects in species ranging from mouse to man (Krutzfeldt et al., 2005; Esau et al., 2006; Elmen et al., 2008; Elmen et al., 2008; Santaris unpublished observation).”
Miranda, K. C., Huynh, T., Tay, Y., Ang, Y.-S., Tam, W.-L., Thomson, A. M., Lim, B., & Rigoutsos, I. (2006) · Cell · doi:10.1016/j.cell.2006.07.031 · Cited by 2,063
Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways
Grimm, D., Streetz, K. L., Jopling, C. L., Storm, T. A., Pandey, K., Davis, C. R., Marion, P., Salazar, F., & Kay, M. A. (2006) · Nature · doi:10.1038/nature04791 · Cited by 1,677 · cited 5×
“Whether exogenous microRNA mimetics can be delivered at concentrations that achieve those resulting from shRNA overexpression (Grimm et al., 2006) has yet to be established, but these results suggest the nature of the effects of RISC saturation and other micro-RNA processing activities that could be expected in the ex…”
InfluentialLNA-mediated microRNA silencing in non-human primates
Elmén, J., Lindow, M., Schütz, S., Lawrence, M., Petri, A., Obad, S., Lindholm, M., Hedtjärn, M., Hansen, H. F., Berger, U., et al. (2008) · Nature · doi:10.1038/nature06783 · Cited by 1,589 · cited 2×
“Using anti-miRs or antagomiRs to inhibit miR-122, multiple laboratories have demonstrated dose-dependent pharmacologic effects in species ranging from mouse to man (Krutzfeldt et al., 2005; Esau et al., 2006; Elmen et al., 2008; Elmen et al., 2008; Santaris unpublished observation).”
Zhang, L., Hou, D., Chen, X., Li, D., Zhu, L., Zhang, Y., Li, J., Bian, Z., Liang, X., Cai, X., et al. (2012) · Cell Research · doi:10.1038/cr.2011.158 · Cited by 1,216 · cited 1×
“There is a report of a microRNA entering the circulation via the diet and being detected in target organs like the liver (Zhang et al., 2012) suggesting that some microRNAs or mimetics can be absorbed and can produce phenotypic changes.”
New microRNAs from mouse and human
LAGOS-QUINTANA, M., RAUHUT, R., MEYER, J., BORKHARDT, A., & TUSCHL, T. (2003) · RNA · doi:10.1261/rna.2146903 · Cited by 909 · cited 2×
“, 2001; Lee and Ambros, 2001), and is now known to be highly conserved in both sequence and developmental expression in organisms spanning wide evolutionary distance (Pasquinelli et al., 2000; Lagos-Quintana et al., 2003; Pasquinelli et al., 2003; Lee et al., 2007).”
miR-375 maintains normal pancreatic α- and β-cell mass
Poy, M. N., Hausser, J., Trajkovski, M., Braun, M., Collins, S., Rorsman, P., Zavolan, M., & Stoffel, M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810550106 · Cited by 740
Cited by
Mogilyansky, E., & Rigoutsos, I. (2013) · Cell Death & Differentiation · doi:10.1038/cdd.2013.125 · Cited by 889
“Glimpses of evidence supporting the ‘expanded’ model were also observed experimentally in earlier work as well as discussed in the literature.(110,112,124,130,142) The members of miR-17/92 clusters are ideal miRNAs for which to explore ‘unexpected targets’ under the ‘expanded’ model.”
The innate immune function of airway epithelial cells in inflammatory lung disease
Hiemstra, P. S., McCray, P. B., & Bals, R. (2015) · European Respiratory Journal · doi:10.1183/09031936.00141514 · Cited by 422
Going beyond the liver: progress and challenges of targeted delivery of siRNA therapeutics
Lorenzer, C., Dirin, M., Winkler, A.-M., Baumann, V., & Winkler, J. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.02.003 · Cited by 284
“The recently expanding knowledge about microRNAs (miRNA) has quickly prompted the development of miRNA-mimicking oligonucleotides for therapeutic applications [45].”
BackgroundGallant-Behm, C. L., Piper, J., Lynch, J. M., Seto, A. G., Hong, S. J., Mustoe, T. A., Maari, C., Pestano, L. A., Dalby, C. M., Jackson, A. L., et al. (2019) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2018.11.007 · Cited by 278
Self-citationParsi, S., Smith, P. Y., Goupil, C., Dorval, V., & Hébert, S. S. (2015) · Molecular Therapy - Nucleic Acids · doi:10.1038/mtna.2015.33 · Cited by 83
Metadata
- Authors
- Jackson, A. L., & Levin, A. A.
- Venue
- Nucleic Acid Therapeutics
- Publisher
- SAGE Publications
- Published
- 2012-08
- Volume
- 22
- Issue
- 4
- Pages
- 213-225
- ISSN
- 2159-3337 (ISSN-L)
- 2159-3345
- OpenAlex
- W1462966185
- Cited by
- 52
- References
- 17
- FWCI
- 2.92
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Developing microRNA Therapeutics: Approaching the Unique Complexities. https://app.cochat.ai/papers/10.1089/nat.2012.0356
- The paper
- Jackson, A. L., & Levin, A. A. (2012). Developing microRNA Therapeutics: Approaching the Unique Complexities. Nucleic Acid Therapeutics. https://doi.org/10.1089/nat.2012.0356
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.